VWM
EXAS

Vermillion Wealth Management’s Exact Sciences EXAS Stock Holding History

Vermillion Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38
Closed -$3.86K – 1564
2025
Q4 		$3.86K Hold
38
– – ﹤0.01% 469
2025
Q3 		$2.08K Hold
38
– – ﹤0.01% 1388
2025
Q2 		$2.02K Hold
38
– – ﹤0.01% 449
2025
Q1 		$1.65K Hold
38
– – ﹤0.01% 1200
2024
Q4 		$2.13K Buy
+38
New +$2.37K ﹤0.01% 442

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Vermillion Wealth Management's EXAS Position: Q1 2026 in Review

Vermillion Wealth Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 38 shares — an estimated $3.86K sold.

Vermillion Wealth Management first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $3.86K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Vermillion Wealth Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 38 Exact Sciences shares in Q1 2026, an estimated $3.86K.
  • Vermillion Wealth Management first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
  • Vermillion Wealth Management's Exact Sciences position peaked at $3.86K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Vermillion Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.